Certified by Founder Lodge
Oxford Cancer Analytics
United Kingdom - Oxford, England
START UP
1 Disclosed Funding Rounds $11,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Oxford Cancer Analytics Ltd (OXcan) is on a mission to enable curative cancer treatments through early detection. OXcan's machine learning platform enables minimally invasive and inexpensive
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| January, 10 ,2025 | Series A | $11,000,000 |
Cross-Border Impact Ventures
DigitalDx Ventures
Civilization Ventures
Eka Ventures
We Venture Capital
IDRx
CAMP4 Therapeutics
Delfi Diagnostics
xilis
Manifold Bio
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
